Published: 18 February 2020
Author(s): A. Maloberti, R.M. Bruno, R. Facchetti, G. Grassi, S. Taddei, L. Ghiadoni, C. Giannattasio
Section: Letter to the Editor

Metabolic Syndrome (MS) is a cluster of elevated Blood Pressure (BP) and glucose, lipids alterations (elevated triglycerides or low HDL-cholesterol) and abdominal obesity that has been associated with a significant increase in Cardio-Vascular (CV) events and mortality [1]. It is highly prevalent in hypertensive patients [2] but data on the longitudinal trends of BP values in hypertensives with and without MS are very limited [3, 4]. Furthermore, MS is characterized by an increase in Pulse Wave Velocity (PWV) but this relationship has been poorly evaluated in longitudinal studies.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.